Key result
Atenolol monotherapy linked to elevated 1-hour post-load glucose in ~94% of nondiabetic patients.
Why the study?
Atenolol remains a relatively common option for treating high blood pressure, but its potential to alter carbohydrate metabolism is considered an obstacle to systematic use, motivating an assessment of glycaemic control alterations in patients receiving atenolol monotherapy.
Cross-Sectional (n=50)
No
Answers are grounded in this paper and cite their sources.
May warrant glucose monitoring with atenolol; hypothesis-generating for diabetes risk in observational data.
Beta-blockers have been used for decades in the treatment of high blood pressure and among them, atenolol continúto being a relatively common option.Among its side effects is the alteration in carbohydrate metabolism, which is currently considered an obstacle to its systematic use.We conducted a study with 50 patients who use this drug as a single therapy to identify alterations in glycaemic control in them.Fasting, immediate post-pandrial (30 minutes) and 1 st and 2 nd hours after glucose overload were determined.In no case was the presence of diabetes mellitus, however, in more than a third of them there were plasma blood glucose levels in the range of "glucose tolerance disorder" in samples taken fasting and post-pandrial immediately, while in the 1st and 2nd hour after gluco seoverload, significant levels of said "glucose tolerance disorder" were identified, which involves a potential risk protein glycosylation It is concluded that this metabolic disorder is very common in patients who use atenolol as a single drug in their treatment and that adequate attention to lifestyle modifications and dietary habits is probably necessary in patients who decide to indicate this drug as an anti-hypertensive drug.
No takes yet. Share an insight, caveat, or question.
Adalberto Fortún Prieto (2019) conducted a cross-sectional in Hypertension (n=50). Atenolol monotherapy was evaluated on Elevated 1-hour post-glucose overload plasma glycemia (>6.1 mmol/L). Atenolol monotherapy in nondiabetic hypertensive patients was associated with elevated blood glucose levels in 72% at fasting/30 minutes, 94% at 1 hour, and 84% at 2 hours post-glucose overload.
Synapse has enriched 10 related papers. Consider them for comparative context: